Short Interest in Basilea Pharmaceutica AG (OTCMKTS:BPMUF) Decreases By 14.4%

Basilea Pharmaceutica AG (OTCMKTS:BPMUF) was the target of a significant decrease in short interest in July. As of July 31st, there was short interest totalling 72,300 shares, a decrease of 14.4% from the July 15th total of 84,500 shares. Based on an average trading volume of 100 shares, the days-to-cover ratio is currently 723.0 days.

Basilea Pharmaceutica Stock Performance

OTCMKTS:BPMUF opened at $47.00 on Monday. Basilea Pharmaceutica has a 12 month low of $38.60 and a 12 month high of $48.15. The firm has a fifty day simple moving average of $47.64 and a two-hundred day simple moving average of $44.47.

Basilea Pharmaceutica Company Profile

Basilea Pharmaceutica AG, a commercial-stage biopharmaceutical company, focuses on the development of products that address the medical needs in the therapeutic areas of oncology and anti-infectives. The company offers Cresemba, an intravenous and antifungal drug for the treatment of invasive aspergillosis and mucormycosis in the United States, and the European Union.